AMETEK, Inc. $AME Shares Sold by Mirabaud & Cie SA

Mirabaud & Cie SA trimmed its holdings in shares of AMETEK, Inc. (NYSE:AME) by 23.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,300 shares of the technology company’s stock after selling 2,500 shares during the period. AMETEK comprises 0.5% of Mirabaud & Cie SA’s investment portfolio, making the stock its 25th biggest holding. Mirabaud & Cie SA’s holdings in AMETEK were worth $1,704,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the business. Sivia Capital Partners LLC purchased a new position in AMETEK in the second quarter worth $295,000. Mackenzie Financial Corp boosted its position in shares of AMETEK by 4.4% during the 2nd quarter. Mackenzie Financial Corp now owns 24,657 shares of the technology company’s stock worth $4,462,000 after purchasing an additional 1,045 shares in the last quarter. VestGen Advisors LLC acquired a new position in shares of AMETEK during the 2nd quarter worth $208,000. Arrowstreet Capital Limited Partnership grew its stake in shares of AMETEK by 93.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 422,617 shares of the technology company’s stock worth $76,477,000 after purchasing an additional 204,044 shares during the period. Finally, Maren Capital LLC increased its holdings in shares of AMETEK by 5.8% in the 2nd quarter. Maren Capital LLC now owns 804,473 shares of the technology company’s stock valued at $145,578,000 after purchasing an additional 44,098 shares in the last quarter. 87.43% of the stock is owned by institutional investors and hedge funds.

AMETEK Price Performance

Shares of NYSE AME opened at $218.84 on Thursday. The company has a current ratio of 1.06, a quick ratio of 0.67 and a debt-to-equity ratio of 0.10. The company’s 50-day moving average price is $224.78 and its 200 day moving average price is $206.48. AMETEK, Inc. has a 52 week low of $145.02 and a 52 week high of $242.05. The stock has a market cap of $50.13 billion, a price-to-earnings ratio of 34.19, a PEG ratio of 3.08 and a beta of 1.02.

AMETEK (NYSE:AME) last announced its earnings results on Tuesday, February 3rd. The technology company reported $2.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.07. AMETEK had a net margin of 20.00% and a return on equity of 16.55%. The company had revenue of $2 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same quarter in the previous year, the business posted $1.87 earnings per share. The firm’s quarterly revenue was up 13.4% compared to the same quarter last year. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. As a group, research analysts forecast that AMETEK, Inc. will post 7.15 earnings per share for the current fiscal year.

AMETEK Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Monday, March 16th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Monday, March 16th. This is an increase from AMETEK’s previous quarterly dividend of $0.31. AMETEK’s dividend payout ratio is currently 21.25%.

Insider Transactions at AMETEK

In other AMETEK news, Director Thomas A. Amato sold 530 shares of the stock in a transaction on Tuesday, March 24th. The stock was sold at an average price of $216.78, for a total transaction of $114,893.40. Following the sale, the director owned 4,480 shares in the company, valued at approximately $971,174.40. This represents a 10.58% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.54% of the company’s stock.

Analyst Ratings Changes

AME has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft began coverage on shares of AMETEK in a report on Wednesday, January 21st. They set a “buy” rating and a $271.00 price objective on the stock. Melius Research set a $235.00 target price on shares of AMETEK in a report on Monday, January 5th. Weiss Ratings reissued a “buy (b)” rating on shares of AMETEK in a research note on Wednesday, January 21st. Wall Street Zen upgraded AMETEK from a “hold” rating to a “buy” rating in a report on Sunday, February 22nd. Finally, Robert W. Baird dropped their price objective on AMETEK from $245.00 to $235.00 and set a “neutral” rating for the company in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $244.67.

About AMETEK

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.